Cornelia Gallo
Child & Adolescent Psychiatry · Westport, CTNPI 1023211653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 26.8% of the total. Among child & adolescent psychiatry clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Tris Pharma Inc$2K
- Alkermes, Inc.$893
- Corium, LLC$593
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$342
- Vanda Pharmaceuticals Inc.$314
- plus $1K from 8 others
What the payments were for
- Food & beverage$6,721100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 109 | $1,806 |
| Tris Pharma Inc | 84 | $1,591 |
| Alkermes, Inc. | 52 | $893 |
| Corium, LLC | 42 | $593 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $342 |
| Vanda Pharmaceuticals Inc. | 5 | $314 |
| Axsome Therapeutics, Inc. | 12 | $305 |
| Sunovion Pharmaceuticals Inc. | 13 | $232 |
| Bausch Health US, LLC | 10 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $186 |
| Supernus Pharmaceuticals, Inc. | 3 | $155 |
| Ironshore Pharmaceuticals Inc. | 3 | $59 |
| Neos Therapeutics, LP | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$484
- Fanapt$250
- Auvelity$227
- QELBREE$125
- Dyanavel XR$124
- Quillichew ER$124
- Quillivant$124
How this compares
$6,734 in reported general payments places this provider in the 95th percentile of 71 child & adolescent psychiatry providers in Connecticut.
See all child & adolescent psychiatry providers in Connecticut →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 37 | $95,947 |
| VraylarCariprazine Hcl | 14 | $18,497 |
| Chlorpromazine Hcl | 39 | $11,205 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $8,486 |
| Aripiprazole | 35 | $4,966 |
| Paliperidone ErPaliperidone | 29 | $3,846 |
| Trazodone Hcl | 34 | $1,190 |
| Alprazolam ErAlprazolam | 18 | $887 |
| Methylphenidate Hcl | 17 | $683 |
| Divalproex Sodium | 19 | $552 |
| Lurasidone Hcl | 14 | $516 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $483 |
| Divalproex Sodium ErDivalproex Sodium | 29 | $460 |
| Sertraline Hcl | 48 | $433 |
| FenofibrateFenofibrate Nanocrystallized | 13 | $413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,806 | $18,49714 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $186 | $8,48614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 71 child & adolescent psychiatry providers in Connecticut.
Other child & adolescent psychiatry in Westport
- Ilana KarpenosWestport$2K
- Tamela AmiriWestport$662
- Jennifer LeeWestport$61
- Karen HotchkissWestport$34
- Steven SpectorPlantsville$278K
- Claudia CarbonariGlastonbury$12K
- Daniel KelleherDanbury$10K
- Allan JacobsWest Hartford$5K
- Robert KhalilDanbury$4K
- Aura ArdonDanbury$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.